2-methyladenine is a naturally occurring purine derivative found in various biological systems. It is often found as a component of tRNA, where it plays a role in the recognition of specific codons during protein synthesis. Research on 2-methyladenine focuses on its biological significance, its role in gene expression, and its potential therapeutic applications. Notable applications include its use as a biomarker for certain cancers and its potential to modulate immune responses. Its synthesis can be achieved via various methods, including chemical modification of adenine or through enzymatic reactions. 2-methyladenine has also been shown to exhibit antiviral activity against certain viruses, further highlighting its biological and therapeutic potential.'
methyladenine : Any member of the class of 6-aminopurines that is adenine bearing a single methyl substituent.
ID Source | ID |
---|---|
PubMed CID | 15048 |
CHEMBL ID | 330897 |
SCHEMBL ID | 19779 |
MeSH ID | M0138134 |
Synonym |
---|
nsc 26364 |
2-methyl-1h-purin-6-amine , |
2-methyl-9h-purin-6-ylamine |
bdbm50030961 |
(2-methyl-9h-purin-6-yl)-amine |
nsc-26364 |
nsc26364 |
sq 23354 |
1h-purin-6-amine, 2-methyl- |
adenine, 2-methyl- |
sq 23,354 |
2-methyl-6-aminopurine |
2-methyl-9h-purin-6-amine |
1445-08-5 |
2-methyladenine |
2-methyl-7h-purin-6-amine |
CHEMBL330897 , |
A808223 |
2-methyl-7h-purin-6-amine;2-methyl-1h-purin-6-amine |
AKOS006338122 |
AKOS015905348 |
SCHEMBL19779 |
2-methyladenin |
SMADWRYCYBUIKH-UHFFFAOYSA-N |
methyladenine |
1h-purin-6-amine, 2-methyl- (9ci) |
AKOS024463815 |
DTXSID80162731 |
mfcd01674065 |
methyl-3h-adenine |
DS-8040 |
1h-purin-6-amine,2-methyl- |
Q15632702 |
1h-purin-6-amine pound not 2-methyl- (9ci) |
BCP29033 |
9h-purin-6-amine, 2-methyl- |
D84317 |
BAA44508 |
CS-0186661 |
J5S7AW6A3C |
sq-23354 |
Pathway | Proteins | Compounds |
---|---|---|
2-methyladeninyl adenosylcobamide biosynthesis from adenosylcobinamide-GDP | 3 | 8 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | IC50 (µMol) | 8,000.0000 | 6.0000 | 7.3333 | 8.0000 | AID75706; AID75716; AID75728 |
Cyclin-dependent kinase 1 | Homo sapiens (human) | IC50 (µMol) | 320.0000 | 0.0004 | 1.3452 | 10.0000 | AID51554 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (50.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.53) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |